CIK: 0001534261 · Show all filings
Period: Q2 2018 (← Previous) (Next →)
Filing Date: Aug 20, 2018
Total Value ($000): $715,025 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | FOUNDATION MEDICINE INC | 685,000 | $93,640 | 13.1% | $50.19 | — | COM | 350465100 |
| — | LOXO ONCOLOGY INC | 360,000 | $62,453 | 8.7% | $28.44 | — | COM | 548862101 |
| — | BLUEPRINT MEDICINES CORP | 635,000 | $40,310 | 5.6% | $49.44 | — | COM | 09627Y109 |
| — | SAGE THERAPEUTICS INC | 250,000 | $39,133 | 5.5% | $52.53 | — | COM | 78667J108 |
| — | MYOKARDIA INC | 780,000 | $38,727 | 5.4% | $29.88 | — | COM | 62857M105 |
| — | SPARK THERAPEUTICS INC | 463,000 | $38,318 | 5.4% | $58.74 | — | COM | 84652J103 |
| — | BLUEBIRD BIO INC | 200,000 | $31,390 | 4.4% | $126.58 | — | COM | 09609G100 |
| AGIO | AGIOS PHARMACEUTICALS INC | 364,776 | $30,725 | 4.3% | $57.83 | +50.8% | COM | 00847X104 |
| FATE | FATE THERAPEUTICS INC | 2,600,000 | $29,484 | 4.1% | $4.33 | +154.5% | COM | 31189P102 |
| CDXS | CODEXIS INC | 2,025,000 | $29,160 | 4.1% | $5.90 | +120.9% | COM | 192005106 |
| — | MAGENTA THERAPEUTICS INC | 2,035,818 | $27,484 | 3.8% | $13.50 | — | COM | 55910K108 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 270,000 | $26,592 | 3.7% | $85.55 | +15.9% | COM | 02043Q107 |
| VYGR | VOYAGER THERAPEUTICS INC | 1,135,000 | $22,178 | 3.1% | $14.86 | — | COM | 92915B106 |
| — | GLOBAL BLOOD THERAPEUTICS IN | 480,000 | $21,696 | 3.0% | $32.45 | — | COM | 37890U108 |
| — | GENMARK DIAGNOSTICS INC | 3,400,000 | $21,692 | 3.0% | $6.84 | — | COM | 372309104 |
| ILMN | ILLUMINA INC | 71,500 | $19,969 | 2.8% | $196.93 | +29.2% | COM | 452327109 |
| SGMO | SANGAMO THERAPEUTICS INC | 1,400,000 | $19,880 | 2.8% | $4.96 | +235.2% | COM | 800677106 |
| — | AUDENTES THERAPEUTICS INC | 450,000 | $17,195 | 2.4% | $19.14 | — | COM | 05070R104 |
| CRSP | CRISPR THERAPEUTICS AG | 220,000 | $12,927 | 1.8% | $47.34 | +20.3% | NAMEN AKT | H17182108 |
| EVH | EVOLENT HEALTH INC | 550,000 | $11,578 | 1.6% | $17.59 | +7.6% | CL A | 30050B101 |
| BLFS | BIOLIFE SOLUTIONS INC | 1,000,000 | $11,410 | 1.6% | $9.10 | 0.0% | COM NEW | 09062W204 |
| ONC | BEIGENE LTD | 70,000 | $10,761 | 1.5% | $149.93 | — | SPONSORED ADR | 07725L102 |
| OSUR | ORASURE TECHNOLOGIES INC | 640,000 | $10,541 | 1.5% | $17.66 | -4.4% | COM | 68554V108 |
| — | CLOVIS ONCOLOGY INC | 220,000 | $10,003 | 1.4% | $71.97 | — | COM | 189464100 |
| EDIT | EDITAS MEDICINE INC | 178,333 | $6,390 | 0.9% | $24.34 | +45.5% | COM | 28106W103 |
| NEOG | NEOGEN CORP | 65,000 | $5,212 | 0.7% | $30.13 | +22.4% | COM | 640491106 |
| CTMX | CYTOMX THERAPEUTICS INC | 207,500 | $4,743 | 0.7% | $17.02 | +50.1% | COM | 23284F105 |
| — | NEON THERAPEUTICS INC | 338,345 | $4,263 | 0.6% | $12.60 | — | COM | 64050Y100 |
| — | LOXO ONCOLOGY INC | 20,000 | $3,470 | 0.5% | $28.44 | — | Put | 548862101 |
| ZLAB | ZAI LAB LTD | 135,000 | $3,139 | 0.4% | $21.35 | — | ADR | 98887Q104 |
| — | JOUNCE THERAPEUTICS INC | 375,000 | $2,873 | 0.4% | $18.19 | — | COM | 481116101 |
| CDNA | CAREDX INC | 200,000 | $2,448 | 0.3% | $11.47 | 0.0% | COM | 14167L103 |
| — | HOMOLOGY MEDICINES INC | 115,000 | $2,346 | 0.3% | $19.51 | — | COM | 438083107 |
| — | GLOBAL BLOOD THERAPEUTICS IN | 50,000 | $2,260 | 0.3% | $32.45 | — | Put | 37890U108 |
| — | BLUEPRINT MEDICINES CORP | 10,000 | $635 | 0.1% | $49.44 | — | Call | 09627Y109 |